A Randomized, Controlled Trial of Heparin Versus Placebo Infusion to Prolong the Usability of Peripherally Placed Percutaneous Central Venous Catheters (PCVCs) in Neonates: The HIP (Heparin Infusion for PCVC) Study
- 1 January 2007
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 119 (1), e284-e291
- https://doi.org/10.1542/peds.2006-0529
Abstract
BACKGROUND. Mechanical and infectious complications shorten the effective duration of peripherally inserted central venous catheters. Heparin use to prevent such complications and prolong the usability of peripherally inserted central venous catheters is inconclusive. OBJECTIVE. Our goal was to evaluate the effectiveness of heparin in prolonging the usability of peripherally inserted central venous catheters in neonates. DESIGN/METHODS. We performed a multicenter, randomized, controlled trial of heparin infusion (0.5 U/kg per hour) versus placebo for peripherally inserted central venous catheters in neonates. The primary outcome was duration of catheter use. Secondary outcomes were occlusion, catheter-related sepsis, thrombosis, and adverse effects of heparin. To detect a 168-hour (1-week) difference in the duration of catheter use, 192 patients were needed. Kaplan-Meier and Cox regression analyses were performed. RESULTS. A total of 201 neonates were enrolled (heparin group: n = 100; control group: n = 101). Baseline demographics were similar between the groups. Duration of catheter use was longer in the infants in the heparin versus the placebo group. Study center, gender, birth weight, and type and position of the catheter were not predictors of duration of catheter use. For those in the heparin versus the placebo group, the incidence of elective catheter removal (therapy completed) was 63% vs 42%, of occlusion was 6% vs 31%, of thrombosis was 20% vs 21%, and of catheter-related sepsis was 10% vs 6%, respectively. No adverse events were noted. CONCLUSIONS. Heparin infusion prolonged the duration of peripherally inserted central venous catheter usability, which permitted a higher percentage of neonates to complete therapy without increasing adverse effects.This publication has 26 references indexed in Scilit:
- Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous cathetersPublished by Wiley ,2005
- Umbilical artery catheters in the newborn: effects of heparinEmergencias, 1999
- Umbilical artery catheters in the newborn: effects of catheter materialsEmergencias, 1999
- Accuracy of sonography in the evaluation of calf deep vein thrombosis in both postoperative surveillance and symptomatic patients.American Journal of Roentgenology, 1996
- The efficacy of heparin in maintaining peripheral infusions in neonatesEuropean Journal of Pediatrics, 1995
- Catheter-related thrombosis in critically ill children: Comparison of catheters with and without heparin bondingThe Journal of Pediatrics, 1995
- Central venous catheter-related complications in newborns and infants: A 587-case surveyJournal of Pediatric Surgery, 1991
- Neonatal thrombotic disease: Prevention, diagnosis, and treatmentThe Journal of Pediatrics, 1988
- Heparin Use as a Risk Factor for Intraventricular Hemorrhage in Low-Birth-Weight InfantsThe New England Journal of Medicine, 1986
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978